サマリー

世界の牛胎児血清市場 2024-2028
牛胎児血清市場は2023-2028年に2億9416万米ドルの成長が予測され、予測期間中のCAGRは5.25%で加速すると予測されています。当レポートでは、牛胎児血清市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、幹細胞アプリケーションの採用の増加、慢性疾患の有病率の増加、畜産業の成長によって牽引されています。
Technavio社の牛胎児血清市場は以下のようにセグメント分けされています：
用途別
- バイオ医薬品
- ヒトおよび動物用ワクチン
- その他
エンドユーザー別
- 製薬・バイオ医薬品企業
- 受託研究機関
- 学術・研究機関
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間の牛胎児血清市場の成長を促進する主な理由の一つとして、細胞ベースの製薬研究における用途の拡大を挙げている。また、疾病管理への注目の高まりと予防医療の採用の増加は、市場の大きな需要につながる。
牛胎児血清市場に関するレポートは以下の分野をカバーしています：
- 牛胎児血清市場のサイジング
- 牛胎児血清市場予測
- 牛胎児血清市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させるのに役立つよう設計されており、これに沿って、本レポートでは、Animal Technologies Inc.、Atlas Biologicals Inc.、Bio Techne Corp.、Corning Inc.、Danaher Corp、GeminiBio、GeneTex Inc.、Grifols SA、HiMedia Laboratories Pvt.Ltd.、伊藤ハム米久ホールディングス株式会社、Merck KGaA、MP Biomedicals Inc.、Nucleus Biologics、PAN Biotech、Rocky Mountain Biologicals、Sartorius AG、TCS Biosciences Ltd.、Thermo Fisher Scientific Inc.、Tissue Culture Biologicals、Celtic Molecular Diagnosticsを含む。また、牛胎児血清市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、包括的な市場およびベンダーの状況と主要ベンダーの分析が含まれています。本レポートの詳細については、https://www.technavio.com/report/fetal-bovine-serum-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータを分析することにより、複数の情報源からのデータを調査、統合、集計し、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global fetal bovine serum market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global fetal bovine serum market 2018 - 2022 ($ million)
o 4.2 Application Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Biopharmaceuticals - Market size and forecast 2023-2028
o Exhibit 34: Chart on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
o 6.4 Human and animal vaccine - Market size and forecast 2023-2028
o Exhibit 38: Chart on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
o 6.5 Others - Market size and forecast 2023-2028
o Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Application
o Exhibit 46: Market opportunity by Application ($ million)
o Exhibit 47: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 50: Chart on Comparison by End-user
o Exhibit 51: Data Table on Comparison by End-user
o 7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
o Exhibit 52: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
o 7.4 Contract research organization - Market size and forecast 2023-2028
o Exhibit 56: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
o 7.5 Academic and research organization - Market size and forecast 2023-2028
o Exhibit 60: Chart on Academic and research organization - Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Academic and research organization - Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Academic and research organization - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Academic and research organization - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by End-user
o Exhibit 64: Market opportunity by End-user ($ million)
o Exhibit 65: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Denmark - Market size and forecast 2023-2028
o Exhibit 91: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Denmark - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 India - Market size and forecast 2023-2028
o Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Animal Technologies Inc.
o Exhibit 115: Animal Technologies Inc. - Overview
o Exhibit 116: Animal Technologies Inc. - Product / Service
o Exhibit 117: Animal Technologies Inc. - Key offerings
o 12.4 Atlas Biologicals Inc.
o Exhibit 118: Atlas Biologicals Inc. - Overview
o Exhibit 119: Atlas Biologicals Inc. - Product / Service
o Exhibit 120: Atlas Biologicals Inc. - Key offerings
o 12.5 Bio Techne Corp.
o Exhibit 121: Bio Techne Corp. - Overview
o Exhibit 122: Bio Techne Corp. - Business segments
o Exhibit 123: Bio Techne Corp. - Key offerings
o Exhibit 124: Bio Techne Corp. - Segment focus
o 12.6 Corning Inc.
o Exhibit 125: Corning Inc. - Overview
o Exhibit 126: Corning Inc. - Business segments
o Exhibit 127: Corning Inc. - Key news
o Exhibit 128: Corning Inc. - Key offerings
o Exhibit 129: Corning Inc. - Segment focus
o 12.7 Danaher Corp.
o Exhibit 130: Danaher Corp. - Overview
o Exhibit 131: Danaher Corp. - Business segments
o Exhibit 132: Danaher Corp. - Key news
o Exhibit 133: Danaher Corp. - Key offerings
o Exhibit 134: Danaher Corp. - Segment focus
o 12.8 Grifols SA
o Exhibit 135: Grifols SA - Overview
o Exhibit 136: Grifols SA - Business segments
o Exhibit 137: Grifols SA - Key offerings
o Exhibit 138: Grifols SA - Segment focus
o 12.9 HiMedia Laboratories Pvt. Ltd.
o Exhibit 139: HiMedia Laboratories Pvt. Ltd. - Overview
o Exhibit 140: HiMedia Laboratories Pvt. Ltd. - Product / Service
o Exhibit 141: HiMedia Laboratories Pvt. Ltd. - Key offerings
o 12.10 Itoham Yonekyu Holdings Inc.
o Exhibit 142: Itoham Yonekyu Holdings Inc. - Overview
o Exhibit 143: Itoham Yonekyu Holdings Inc. - Business segments
o Exhibit 144: Itoham Yonekyu Holdings Inc. - Key offerings
o Exhibit 145: Itoham Yonekyu Holdings Inc. - Segment focus
o 12.11 Merck KGaA
o Exhibit 146: Merck KGaA - Overview
o Exhibit 147: Merck KGaA - Business segments
o Exhibit 148: Merck KGaA - Key news
o Exhibit 149: Merck KGaA - Key offerings
o Exhibit 150: Merck KGaA - Segment focus
o 12.12 PAN Biotech
o Exhibit 151: PAN Biotech - Overview
o Exhibit 152: PAN Biotech - Product / Service
o Exhibit 153: PAN Biotech - Key offerings
o 12.13 Rocky Mountain Biologicals
o Exhibit 154: Rocky Mountain Biologicals - Overview
o Exhibit 155: Rocky Mountain Biologicals - Product / Service
o Exhibit 156: Rocky Mountain Biologicals - Key offerings
o 12.14 Sartorius AG
o Exhibit 157: Sartorius AG - Overview
o Exhibit 158: Sartorius AG - Business segments
o Exhibit 159: Sartorius AG - Key news
o Exhibit 160: Sartorius AG - Key offerings
o Exhibit 161: Sartorius AG - Segment focus
o 12.15 TCS Biosciences Ltd.
o Exhibit 162: TCS Biosciences Ltd. - Overview
o Exhibit 163: TCS Biosciences Ltd. - Product / Service
o Exhibit 164: TCS Biosciences Ltd. - Key offerings
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 165: Thermo Fisher Scientific Inc. - Overview
o Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 167: Thermo Fisher Scientific Inc. - Key news
o Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Tissue Culture Biologicals
o Exhibit 170: Tissue Culture Biologicals - Overview
o Exhibit 171: Tissue Culture Biologicals - Product / Service
o Exhibit 172: Tissue Culture Biologicals - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global fetal bovine serum market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Application ($ million)
Exhibits47: Data Table on Market opportunity by Application ($ million)
Exhibits48: Chart on End-user - Market share 2023-2028 (%)
Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Academic and research organization - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Academic and research organization - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Academic and research organization - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Academic and research organization - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Denmark - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Animal Technologies Inc. - Overview
Exhibits116: Animal Technologies Inc. - Product / Service
Exhibits117: Animal Technologies Inc. - Key offerings
Exhibits118: Atlas Biologicals Inc. - Overview
Exhibits119: Atlas Biologicals Inc. - Product / Service
Exhibits120: Atlas Biologicals Inc. - Key offerings
Exhibits121: Bio Techne Corp. - Overview
Exhibits122: Bio Techne Corp. - Business segments
Exhibits123: Bio Techne Corp. - Key offerings
Exhibits124: Bio Techne Corp. - Segment focus
Exhibits125: Corning Inc. - Overview
Exhibits126: Corning Inc. - Business segments
Exhibits127: Corning Inc. - Key news
Exhibits128: Corning Inc. - Key offerings
Exhibits129: Corning Inc. - Segment focus
Exhibits130: Danaher Corp. - Overview
Exhibits131: Danaher Corp. - Business segments
Exhibits132: Danaher Corp. - Key news
Exhibits133: Danaher Corp. - Key offerings
Exhibits134: Danaher Corp. - Segment focus
Exhibits135: Grifols SA - Overview
Exhibits136: Grifols SA - Business segments
Exhibits137: Grifols SA - Key offerings
Exhibits138: Grifols SA - Segment focus
Exhibits139: HiMedia Laboratories Pvt. Ltd. - Overview
Exhibits140: HiMedia Laboratories Pvt. Ltd. - Product / Service
Exhibits141: HiMedia Laboratories Pvt. Ltd. - Key offerings
Exhibits142: Itoham Yonekyu Holdings Inc. - Overview
Exhibits143: Itoham Yonekyu Holdings Inc. - Business segments
Exhibits144: Itoham Yonekyu Holdings Inc. - Key offerings
Exhibits145: Itoham Yonekyu Holdings Inc. - Segment focus
Exhibits146: Merck KGaA - Overview
Exhibits147: Merck KGaA - Business segments
Exhibits148: Merck KGaA - Key news
Exhibits149: Merck KGaA - Key offerings
Exhibits150: Merck KGaA - Segment focus
Exhibits151: PAN Biotech - Overview
Exhibits152: PAN Biotech - Product / Service
Exhibits153: PAN Biotech - Key offerings
Exhibits154: Rocky Mountain Biologicals - Overview
Exhibits155: Rocky Mountain Biologicals - Product / Service
Exhibits156: Rocky Mountain Biologicals - Key offerings
Exhibits157: Sartorius AG - Overview
Exhibits158: Sartorius AG - Business segments
Exhibits159: Sartorius AG - Key news
Exhibits160: Sartorius AG - Key offerings
Exhibits161: Sartorius AG - Segment focus
Exhibits162: TCS Biosciences Ltd. - Overview
Exhibits163: TCS Biosciences Ltd. - Product / Service
Exhibits164: TCS Biosciences Ltd. - Key offerings
Exhibits165: Thermo Fisher Scientific Inc. - Overview
Exhibits166: Thermo Fisher Scientific Inc. - Business segments
Exhibits167: Thermo Fisher Scientific Inc. - Key news
Exhibits168: Thermo Fisher Scientific Inc. - Key offerings
Exhibits169: Thermo Fisher Scientific Inc. - Segment focus
Exhibits170: Tissue Culture Biologicals - Overview
Exhibits171: Tissue Culture Biologicals - Product / Service
Exhibits172: Tissue Culture Biologicals - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations